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Background. The major histocompatibility complex class I chain–related 
gene  A  (MICA)  (OMIM-600169)  is  a  polymorphic  gene  in  the  HLA  region 
expressed mainly by epithelial cells. The MICA protein encoded by the allele 
influences the activation of NK cells, which modify  -cells destruction and has 
been found to be involved in susceptibility of T1DM. 
Objective. The aim of this study was to find the association of MICA alleles 
with T1DM among eastern Indian population. 
Subjects and methods. Study was conducted in 134 eastern Indian patients and 
with  137  healthy  controls  for  the  possible  role  of  MICA  gene  in  T1DM 
pathogenesis.  
Results.  The  MICA*A5  microsatellite  allele,  showed  significantly  higher 
frequencies in patients than controls (p=0.003, OR= 1.746, CI= 1.206- 2.528). 
MICA A*6 was found to be protective in our study (p=<0.01, OR=0.406, CI= 
0.268-0.616).  
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INTRODUCTION 
Type  1  diabetes  mellitus  (T1DM;  Online  Mendelian  Inheritance  in  Man-OMIM 
222100) is an autoimmune disease characterized by destruction of the insulin-producing  -cells 
of islets of Langerhan’s of pancreas, leading to absolute insulin deficiency resulting in chronic 612                                                                                                             GENETIKA, Vol. 45, No.2,611-619, 2013 
hyperglycemia (CONCANNON et al. 2005;  ERLICH et al. 2008). T1DM is a polygenic disorder. 
T1DM has its highest incidence among adolescents, with a large number of presenting with 
diabetes in early puberty(Urban 2006).   
The major histocompatibility complex class I chain–related gene A (MICA) (OMIM-
600169) is a polymorphic gene in the HLA region expressed mainly by certain epithelial cells, 
keratinocytes, endothelial cells, fibroblasts, and monocytes. The MICA genes, members of the 
MIC [Major Histocompatibility Complex Class I chain-related] family are spread across the 2-
Mb MHC Class I region (http://www.ncbi.nlm.nih.gov/gv/mhc/main.cgi?cmd=init). The MICA 
gene is the nearest neighbor to HLA-B (only 46 kb centromeric). The MIC-A and MIC-B genes 
contain  long  open-reading  frames  encoding  for  MHC  class  I  molecules  with  three  distinct 
extracellular domains ( 1, 2, and 3), a transmembrane segment, and a cytoplasmatic tail, each 
encoded by a separate exon (SANJEEVI et al. 2002). The expression of MICA gene is induced by 
heat shock and is broadly recognized by a subset of    T-cell that exists predominantly in the 
intestinal and other epithelia (KAWABATA et al.  2000). The broad recognition of  MICA and 
MICB implies an unusual mode of interaction with the Natural Killer Cells (NK) and    T-cell. 
MICA  has  5  exons  and    91  alleles  which  encodes  71  proteins 
(http://www.ebi.ac.uk/imgt/hla/stats.html).. 
The microsatellite polymorphism consists of repetitions of GCT/AGC. (GCT/AGC)n 
encodes polyalanine, and the number of alanine (Ala) residues differs with the number of triplet 
repeats. Five alleles of exon 5 of the MICA gene, each consisting of 4, 5, 6 and 9 repetitions of 
GCT and five repetitions of GCT with an additional G insertion (GGCT), have been identified. 
These  alleles  have  accordingly,  been  named  A4,  A5,  A6,  A9  and  A5.1,  and  their  sizes 
correspond   to   179,   182,   185,   194   and   183 bp, respectively (Mehra et al. 2007). A5.1 
allele  contains  five  triplet  repeats  plus  one  additional  nucleotide  insertion  (GGCT/AGCC), 
causing  a frameshift  mutation leading to a  premature  intradomain  stop  codon  (TAA)  in  the 
transmembrane (TM) region. The MICA protein encoded by A5.1 allele influences the activation 
of NK cells, which modify  -cells destruction and thus involve in the age at onset of T1DM 
(PARK and EISENBARTH 2001). It has been observed that the MICA5.1 gene product expresses 
aberrantly at the apical surface of human intestinal epithelial cells instead  of the basolateral 
surface,  the  site  of  putative  interaction  with  intra-epithelial  T  and  NK  lymphocytes.  Thus, 
MICA5.1-homozygous individuals may have altered immunological surveillance by T and NK 
cells (SUEMIZU et al. 2002 ). 
Different  MICA  polymorphisms  have  shown  various  associations  with  autoimmune 
diabetes in different populations and have also varied with age at onset (BERZINA et al. 2002). 
Significant evidence is there for the association between MICA5.1 and adult-onset T1DM (TORN 
et al. 2004). It is observed that the frequency of A5.1 allele is highest in early-onset patients, 
intermediate  in  intermediate-onset  patients  and  lowest  in  late-onset  patients.  A5.1  allele  is 
strongly  associated  with  HLA-B7  and  Cw7,  suggesting that  MICA*A5.1-B7-Cw7  haplotype 
contains  a  gene  responsible  for  age-at-onset.  A4  allele  was  associated  with  a  susceptible 
haplotype,  DR4-DQB1*0401,  and  A6  allele  is associated  with a  protective  haplotype,  DR2-
DQB1*0601, suggesting that the association of MICA with T1DM Linkage Disequilibrium (LD) 
with Class II haplotypes (GAMBELUNGHE et al. 2001).  
The Swedish study showed that the frequency of MICA*A5 was not associated with 
age in the healthy control group; neither it was significantly associated with the presence of any 
of  the  major  islet  autoantibodies.  This  analysis  revealed  the  independent  associations  of O. RAHA et al: MICA REPEAT POLYMORPHISM IN  TYPE 1 DIABETIS                                                      613 
MICA*A5 and class II gene polymorphism with childhood/young-onset T1DM (age at onset 
before 25 yr). The interaction between the MICA gene and the HLA class II polymorphism was 
revealed by the increase in the presence of both MICA*A5 and HLA-DRB1*03-DQA1*0501-
DQB1*0201  and/or  DRB1*04-DQA1*0301-DQB1*0302  in  young-onset  T1DM 
(GAMBELUNGHE et al. 2001). MICA*A5 was significantly associated with T1DM in the age 
group of 1–25 years at diagnosis in European Caucasians (Gambelunghe et al. 2001). In Indians 
also MICA* A5 allele is associated with T1DM (SANJEEVI et al. 2002). It has been observed that 
patients who are young and below the age of 18 years show higher association with MICA*A5 
allele (SANJEEVI et al. 2002;  KAWABATA et al. 2000).  The contrary reports are also available, 
like the study from Italy which shows negatively associated with age at the clinical onset of 
diabetes (GAMBELUNGHE et al. 2000).  
Meta-analysis also confirmed that the MICA*A5 variant was significantly associated 
with an increased risk for T1DM, while MICA*A6 was significantly associated with a decreased 
risk (SANJEEVI et al. 2002). Depending upon the risked allele is present, MICA*A6 confers either 
susceptibility or protection. For example, MICA alleles when present with T1DM associated 
high-risk MHC Class II haplotypes (DQ2-DR17), reveal that MICA*A6 was associated with an 
increased risk for T1DM. In contrast,  MICA*A6 reduced the risk from the  HLA-DQ8-DR4 
T1DM-risk haplotype. MICA*A9 showed increased risk for T1DM when associated with DQ8-
DR4  haplotypes  and  also  MICA*6  and  MICA*9  are  less  frequently  transmitted  to  affected 
offspring  (ALIZADEH et al. 2007;  FIELD et al. 2008).  
Bengali  ethnic  population  is  a  mixed  breed  of  population  broadly  of  Dravidians, 
Mongols  and  Aryans.  There  is  some  amount  of  admixture  of  aboriginals  like  Mundari  and 
Santhals  (MAZUMDAR 1998).Thus,  it  may  be  stated  that  Bengali  as  a community  is  not  too 
homogeneous (RAHA 1975).  In the present study, we examine whether the results of association 
of certain MICA alleles with T1DM observed in Western populations can be substantiated in our 
population. MICA profiles of T1DM patients are available from various parts of India, though 
they are almost all based on single hospital data (SANJEEVI et al. 2002;  MEHRA et al. 2007;  DAS 
et al. 2002;  DAS et al. 2002;  DATTA et al. 2002;  MEHRA et al. 2001;  MEHRA et al. 2002;  
TANDON et al. 2002) and none of them are from a population. In the present study in order to 
capture the allelic variation of MICA more comprehensively, we designed a sequencing-based 
typing (SBT) method that yields the genotype information for MICA gene for exon 5. The aim of 
this  study  was  to  find  the  association  of  MICA  alleles  with  T1DM  among  eastern  Indian 
population. 
 
MATERIALS AND METHODS 
Materials 
We  collected  intravenous  blood  samples  (10  ml)  from  134  T1DM  cases  and  137 
controls, recruited from six different hospitals – Calcutta Heart and Research Clinic, Kolkata; 
Endocrinology  Department,  Calcutta  Medical  College  and  Hospital,  Kolkata;  Endocrinology 
Department, SSKM Hospital, Kolkata;  Netaji Subhash Chandra Bose Cancer Research Institute, 
Kolkata;  Rabindranath  Research  Institute  of  Cardiac  Sciences,  Kolkata;  School  of  Tropical 
Medicine,  Kolkata.  This  research  was  approved  by  the  Institutional  Review  Board  of  the 
Anthropological Survey of India as well as by the ethical committee of the respective hospitals. 
The present samples comprised of T1DM patients and age, sex and ethnic matched 
controls. Patients with the age of onset of T1DM below 39 years and presenting with or without 614                                                                                                             GENETIKA, Vol. 45, No.2,611-619, 2013 
acute ketosis with absolute insulin dependence as evidenced by a deficient C-peptide secretion 
i.e., a C-peptide value less than 0.5 (0.6-3.2) ng/ml., and a duration of T1DM of at least one year, 
were included. The mean age of patients were 22.80+9.36 and of controls were 37.02+15.61. 
Patients of at least one year duration were selected to exclude acute or “honeymoon” phases.  
Any  participant  with  an  obvious  secondary  cause  like  steroid  therapy  or  fibrocalculous 
pancreatic disease, chronic infection or co-morbid illness was also excluded.  
 
Methods 
DNA was isolated from the above samples following the standard protocol by phenol-
chloroform  method  (SAMBROOK  2001).  We  have  analyzed  the  exon-  5  microsatellite  repeat 
polymorphism  of  the  MICA  gene,  by  PCR  primers  flanking  the  TM  region  (Table  1).  The 
primers were selected from previous work (GAMBELUNGHE et al. 2001;  PARK et al. 2001). A 
total volume of 25µl was used for each PCR reaction. This included: 1.0µl of 10XPCRBuffer 
(containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl and 25mM MgCl2) (Roche Diagnostic, USA) 
0.2µl of 10mM dNTPs (Roche Diagnostic, USA), 20pmol/µl of forward and reverse primers 
(Sigma), 1 unit of Taq polymerase (Roche Diagnostic, USA), and 100ng/µl of human DNA. The 
PCR carried out in an ABI Gene Amp PCR system 9700 were as follows: PCR conditions 96°C- 
10  minutes,  30  PCR  cycles:  96°C-  30  seconds  (denaturation)  gradient  specific  temperature 
(56°C) - 30 seconds (annealing), 72°C- 45 seconds (extension), and two final cycles- 96º C for 
10  min and 4º C for infinity. PAGE was  used  to examine the  number of repeats in MICA 
microsatellite polymorphism. For PAGE, the vertical gel apparatus was used. The samples were 
electrophorosed in 6% polyacrylamide gel. 5 µl of the samples were mixed with 1/6
th volume of 
gel loading dye. Electrophoresis was carried out at 60 volts/cm of the gel for 1.5 to 2.5 hours at 
room temperature depending on the size of the gel and the fragment size To visualize the DNA 
fragments, the gels were stained with ethidium bromide solution (0.5  g/ml) for 30 minutes and 
then de-stained in water for 5 minutes. The PCR products were sequenced through automated 
DNA Analyzer (Applied Biosystems; Foster City, CA, USA).  
 
Table 1. List of primers used in the present study to amplify genes 
Designation  Chromosome 
Location 
Sequence  Annealing 
Temperature 
Product 
Size(bp) 
MICA  6p21.3  F-5’  
CCTTTTTTTCAGGGAAAGTGC      
3’ 
60° C  185 
R-5’  
CCTTACCATCTCCAGAAACTGC   
3’ 
(GAMBELUNGHE et al. 2001;  PARK et al. 2001);  
 
Statistical Analysis 
  All the HLA alleles at each locus were recoded as numbers to facilitate analysis with 
SPSS, v 17.0 for Windows statistical package (SPSS Inc., Chicago, IL). For each of the gene 
studied allele frequencies were calculated between T1DM cases and controls. Allele frequencies 
were estimated by gene counting method. Gene counting was carried out using SPSS.  Odds O. RAHA et al: MICA REPEAT POLYMORPHISM IN  TYPE 1 DIABETIS                                                      615 
ratios were calculated for each gene using SPSS and recoding of the alleles was carried out in 
such a way that an allele with most similar frequency in both cases and controls was coded with 
the highest number to be used as the reference allele. Chi-square ( 
2) analysis was carried out 
using SPSS.  A p-value of < 0.05 was considered to be statistically significant. 
 
RESULTS AND DISCUSSION 
There are multiple conflicting reports in the literature about association of MICA gene 
and T1DM. The studies from Dutch, Italy, Korea, and North India show positive association of 
MICA alleles with T1DM (GAMBELUNGHE et al. 2001;  GAMBELUNGHE et al. 2000;  PARK et al. 
2001); but at the same time, all the studies does not support an independent association between 
MICA variants and T1DM (SANJEEVI et al. 2002;  ALIZADEH et al. 2007;  KUMAR et al. 2012). 
Some studies on trinucleotide STR (GCT/AGC)n in exon 5 of the MICA gene showed 
that allele A4, A5 or A5.1  predisposes to T1DM, and that MICA*A6 protects against T1DM. 
Whereas,  another  study  found  no  association  to  any  of  the  MICA  alleles  in 
T1DM(GAMBELUNGHE et al.  2007).  These findings resulted in  more controversy, with some 
investigators claiming that MICA has an HLA-independent effect on T1DM, whereas, others 
showed that the effect of MICA is confounded by LD between this locus and the HLA Class II 
DQ-DR  haplotypes  including  DQB1*0201-DQA1*0501-DRB1*03  (DQ2DR17)  and 
DQB1*0302-DQA1*0301-DRB1*04 (DQ8DR4) (KAWABATA et al. 2000;  GAMBELUNGHE et al. 
2001;  ALIZADEH et al. 2007;  PARK et al. 2001).  
In our study we identified five alleles with four, five, six, and nine repeats of GCT 
(AGC  for  reverse  primer)  or  five  repeat  of  sequence  GCT  with  one  additional  nucleotide 
insertion  (GGCT).  The  alleles  are  A4,  A5,  A6,  A9,  and  A5.1  respectively.  We  observed  a 
significant positive association between A5 allele (OR=1.746, p=0.003) and T1DM. However, 
negative association was also observed between T1DM and the A6 allele (OR=0.406, CI=0.268-
0.616, p=<0.01) in the present study (Table 1).  
  We also analyzed these samples for possible effect of MICA polymorphism on age 
of onset (Table 2). The result did not show any association with T1DM and age of onset and 
hence MICA gene has possibly no role for age of onset in the studied population.  
Table 2. MICA genotype frequencies amongT1DM cases and controls 
Ex 5 
Micro-
satellite 
Alleles 
Amplified  
Product bp 
Cases 
(Total=268) 
Controls 
(Total=274) 
p-
value 
Odds 
ratio 
CI (95%) 
    N  %  N  %      Lower  Upper 
A4  179  66  24.6  58  21.2  0.338  1.217  0.814  1.818 
A5  182  98  36.6  68  24.8  0.003  1.746  1.206  2.528 
A5.1  183  28  10.4  22  8.0  0.332  1.336  0.744  2.400 
A6  185  42  15.7  86  31.4  <0.01  0.406  0.268  0.616 
A9  194  34  12.7  40  14.6  0.517  0.850  0.520  1.390 
CI=confidence interval 616                                                                                                             GENETIKA, Vol. 45, No.2,611-619, 2013 
Most  of  the  studies  demonstrate  a  positive  association  between  A5/A5.1  allele  and 
T1DM.  In  European  populations,  the  most  common  allele  of  the  MICA-microsatellite  is 
MICA*A5.1 (frequency 0.50), which contains five GCT repeats and a G insertion that causes a 
frame shift, leading to a premature stop codon and the truncation of the cytoplasmic tail. In 
Indian population, MICA*A5 is predominant among T1DM cases (SANJEEVI et al. 2002). The 
study from Cuttack  showed  that MICA*A5 allele is positively associated with T1DM (odds 
ratio(OR) =2.64, p < 0.05) (SANJEEVI et al. 2002). Further reports show association with age of 
onset  (SANJEEVI  et  al.  2002).  The  recent  study  from  North Indian  population,  shows  the 
MIC*A5.1 allele  with  increased  frequency  in  T1DM  (29.6%,  OR = 2.1,  p  =0.00017). 
However, it is also observed that it is in LD with HLA-B8-DR3-DQ2 haplotype (KUMAR et al. 
2012).  
Significant associations between T1DM and MICA gene polymorphisms were observed 
in our Bengali-Indian study population. Our data showed a protective effect for the MICA*A6 
allele. Also, the statistical significance is present for a positive association of the A5 allele with 
the T1DM. This is similar to the North Indian study. Our study and the North Indian study on 
HLA alleles highlights that T1DM patients have some common predisposing alleles such as 
DQA1*0201:DQB1*020101G, DQA1*050101:DQB1*020101G, and DQA1*0201:DQB1*030101G (RAHA et al. 
2013). Though, our study on Insulin VNTR gene did not show any predisposition with T1DM 
(RAHA et al. 2011). 
Eventually, our analysis of MICA Exon5 minisatellite brings forth the significance of 
the gene in the T1DM etiology. It was not only identifying the risk prone alleles but also to 
recognize  the  plausible  protective  alleles  against  T1DM.  The  observation  from  the  present 
population indicates MICA*A6 (31.6%) frequency to be predominant, followed by MICA*A5 
allele (25%) and MICA*A4 allele (21%). 
Table 3:  Allele frequencies of microsatellite polymorphism of MICA with respect to age-at-onset of type 1 
diabetic patients 
Alleles  Age at onset  p-value  Odds ratio  CI (95%) 
  < 20yrs 
(N=108) 
%  >20yrs 
(N=30) 
%  Lower  Upper 
A4  18  16.66  7  23.3  0.70  0.657  5.961  0.072 
A5  47  43.52  16  53.3  0.67  0.674  4.156  0.109 
A5.1  16  14.81  0  -  0.31  -  -  - 
A6  18  16.66  3  10  0.67  1.800  0.101  32.030 
A9  9  8.33  4  13.3  0.70  0.591  9.659  0.036 
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Izvod 
Glavni  kompleks  histokompatibilan  sa  klasom  I  lanca  gena  A  (MICA)  (OMIM-600169)  je 
polimorfan gen u HLA regionu  koji se velikm delom eksprimira u epitelnim  elijama. Utvr eno 
je da je  protein kodiran alelom gena MICA koji aktivira NK  elije koje modifikuju destrukciju 
beta –  elija uklju en u osetlivost T 1DM. Cilj ovih istraživanja  je bio da se utvrdi asocijacija 
MICA alela sa T1DM unutar populacije Indije. Dobijeni podaci pokazuju da MICA×A5 alelni 
mikrosateliti imaju zna ajno ve u u estalost kod obolelih pacijenata u pore enju sa kontrolnim. 
Za MICA A×6 je pokazana zaštitna uloga. 
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